Match Document Document Title
RE38958 Methods and formulations for control of pests  
The subject invention concerns novel biopesticides and their use to control cockroaches, carpenter ants, and pharaoh ants. Specifically, highly virulent isolates of Beauveria bassiana in an...
6991807 Antibiotic composition  
Disclosed are antibiotic products for delivering at least two different antibiotics, wherein the products are comprised of at least three or four dosage forms with different release profiles and...
6989159 Pharmaceutical compositions containing lithium carbonate  
Once daily pharmaceutical compositions containing lithium carbonate in the form of coated granules.
6984404 Methods for preparing coated drug particles and pharmaceutical formulations thereof  
Disclosed are methods using pulsed laser ablation to prepare coated drug particles of uniform size and thickness. The coated drug particles ranged in size from several nanometers to several...
6979466 Nanoscale particles having an iron oxide-containing core enveloped by at least two shells  
The invention relates to nanoscale particles suited especially for use in tumor therapy by hyperthermia. Said particles comprise a (preferably superparamagnetic) iron oxide-containing core and at...
6974594 Method of preparing biological materials and preparations produced using same  
Methods for preparing products containing moisture-sensitive materials, including biological materials such as proteins, peptides or live cells, comprising at least the steps: (i) providing a...
RE38912 Process for preparing powder formulations  
The invention relates to a new process for producing powdered preparations for inhalation.
6972132 System for release in lower digestive tract  
A system whereby a substance which is orally taken and to be delivered into the lower digestive tract is selectively delivered into the lower digestive tract. More particularly, a system which...
6969531 Sodium hyaluronate microspheres  
The present invention relates to microspheres comprising hyaluronan derivatized with a bifunctional crosslinker to form microspheres. Methods of making such microspheres, comprising mixing...
6956043 Pharmaceutical compositions comprising 33-epi-chloro-33-desoxy-ascomycin solid dispersions  
A pharmaceutical composition in the form of a solid dispersion comprising a macrolide, e.g. a rapamycin or an ascomycin, and a carrier medium.
6946146 Coating for a sustained release pharmaceutical composition  
The present invention is directed to a coating composition for coating a solid dosage form of a medicament, where the coating composition controls the release of the medicament, said coating...
6939530 Preparation of further diagnostic agents  
Microspheres are prepared by a process comprising (i) spray-drying a solution or dispersion of a wall-forming material in order to obtain intermediate microspheres and (ii) reducing the...
6936279 Microcrystalline zeaxanthin with high bioavailability in oily carrier formulations  
Zeaxanthin (ZX) or other medically or commercially important carotenoids can be prepared in microcrystalline form, in an oily carrier liquid, to increase their bioavailability following oral...
6936109 Method of producing starch or starch-containing products from starch-containing plant raw materials, starch products, and methods of using starch products  
A method produces starch or starch-containing products from starch-containing plant raw materials. The method is distinguished by the inclusion of an electric pulse method.
6932984 Method of microencapsulation  
A method for microencapsulation of substances is provided. The substance(s) is/are dissolved or dispersed in an organic solvent of the kind that is partially miscible in water media. This organic...
6926910 Hydrophobe biomolecular structure  
The present invention relates to a new hydrophobe biomolecular structure, which is compacted due to the passing of the structure over its point of collapse, a method for the preparation of the...
6921541 Formulations and methods for providing prolonged local anesthesia  
A formulation and methods for inducing sustained regional local anesthesia in a patient comprising a substrate comprising a local anesthetic and an effective amount of a biocompatible,...
6911217 Controlled release bead, a method of producing the same and multiple unit formulation comprising it  
A controlled release bead comprises: (i) a core unit of a substantially water-soluble or water-swellable inert material; (ii) a first layer on the core unit of a substantially water-insoluble...
6903146 Prosthetic filler for a living body and method of manufacturing the prosthetic filler  
A prosthetic filler for a living body having excellent storage properties and handlability is disclosed. The prosthetic filler includes calcium phosphate granules and porous small chips made of an...
6902746 Oral pharmaceutical compositions containing non-steroidal anti-inflammatory drugs and method for preparing the same  
The present invention provides oral pharmaceutical compositions for acetic acid class of non-steroidal anti-inflammatory drug (NSAID), particularly ketorolac. The pharmaceutical composition...
6894071 Medical compositions for intravesical treatment of bladder cancer  
Anti-cancer coating compositions comprising 3-hydroxymethyl-5-aziridinyl-1-1-methyl-2-[1H-indole-4,7-dio ne]propenol (E09) are disclosed. More specifically, the coating compositions comprise EO9...
6890561 Microencapsulated and controlled-release formulations of isoflavone from enriched fractions of soy and other plants  
There is provided an orally-administrable formulation for the controlled release or stable storage of a granulated isoflavone-enriched fraction or mixture of such fractions, comprising at least one...
6887493 Multi component controlled release system for oral care, food products, nutraceutical, and beverages  
The present invention relates to an improved controlled release system that can encapsulate different flavors, sensory markers, and active ingredients, or combinations of flavors, sensory markers...
6884885 Production of cyclodextrin complexes  
The process entails increasing the concentration of cyclodextrin to 15% (w/w) and above to form complexes through a precipitation process in order to increase the yield of complexes, increase the...
6875443 Encapsulated long chain alcohols  
The present invention is directed to the encapsulation of long chain alcohols, C 20 -C 36 , in various materials including polymers and waxes. Through the proper selection of the polymer the...
6875449 Crystal structure  
A process for the production of crystals with controlled surface smoothness, size, shape and degree of crystallinity, compositions comprising such crystals, and the use of certain crystals,...
6849275 Calcium phosphate composition and method of preparing same  
A method for controlling the formation of a hydroxyapatite bone filler from dry calcium phosphate precursors in an aqueous solution uses coated sodium phosphate powder. The sodium phosphate powder...
6843995 Cosmetic preparation containing extracts of Tuberaceae  
The invention relates to a cosmetic preparation containing an active complex comprised of extracts. The active complex contains at least one starting substance, which is extracted as an aqueous...
6841169 Stabilizer for pharmacons  
The present invention relates to an auxiliary substance for an active substance, such as a pharmacon. The auxiliary substance has a stabilizing action. The auxiliary substance further has a...
6828334 Fenofibrate-cyclodextrin inclusion complexes and their pharmaceutical composition  
The present invention relates to pharmaceutical compositions containing fenofibrate in the form of an inclusion complex with cyclodextrin, having high dissolution profile and in vivo enhanced...
6808557 Cellulose matrix encapsulation and method  
A regenerated cellulose-encapsulated active substance and a method for encapsulating an active substance in a regenerated cellulose matrix are disclosed. The distribution of the active substance is...
6809082 Synthetic transfection vectors  
An inorganic particle, to which is bonded a cell binding component and a nucleic acid, is provided for delivery of a nucleic acid to a cell. The disclosed particle acts as a synthetic vector for...
6797835 Phospholipid composition and use of same  
A phospholipidic composition with an L-α-glycerophosphatidyl-choline concentration of at least 10% by weight is described, where said composition is granular and also contains, in addition to...
6794367 Solid preparations for oral administration of drugs relating to genes  
The invention provides solid preparations for oral administration of gene-related drugs comprising a core containing the gene-related drug with a coating which does not disintegrated in small...
6780398 Aqueous nasal formulation  
An aqueous nasal formulation comprising beclomethasone dipropionate anhydrate for use in the treatment of respiratory disorders.
6780435 Omeprazole formulation  
A pharmaceutical composition of omeprazole for oral administration is described which consists essentially of: (a) a pellet comprising an inert core component, a therapeutically effective amount...
6780436 Solid oral pharmaceutical formulation of modified release that contains an acid labile benzimidazole compound  
The pharmaceutical formulation consists of a number of pellets that comprise an inert nucleus, a layer with the active ingredient, one or more intermediate layers that comprise at least a system of...
6777542 Method and apparatus for reducing the calcium and phosphorous ratio and increasing crude protein in shellfish waste meal  
This invention relates to a method and apparatus for the processing of shellfish waste meal. More particularly, to increasing the crude protein while decreasing calcium and phosphorus levels of...
6770305 Electrolyte gels for maintaining hydration and rehydrating  
A gel rehydration electrolyte composition provides a convenient and effective way of replenishing lost fluid and electrolytes. The gel rehydration electrolyte composition masks unpleasant tastes of...
6770299 Lipid matrix-drug conjugates particle for controlled release of active ingredient  
The invention relates to particulate active ingredient vehicles which are in the solid aggregate state at room temperature (20° C.) and consist of a pure lipid-drug conjugate (LDC) or a mixture of...
6761910 Pharmaceutical composition for the treatment of acute disorders  
A pharmaceutical composition for the treatment of acute disorders is described. The composition comprises an essentially water-free, ordered mixture of at least one pharmaceutically active agent in...
6759059 Fentanyl composition for the treatment of acute pain  
A pharmaceutical composition for the treatment of acute pain by sublingual administration is described. The composition comprises an essentially water-free, ordered mixture of fentanyl or a...
6750249 Controlled release oral preparations of esculetin and its derivatives  
The present invention relates to an oral preparation of esculetin with controlled release. The oral preparation of esculetin with controlled release of the present invention comprises a gel-forming...
6749845 Modulated release particles for lung delivery  
A polymeric construct is disclosed. The construct comprises a polysaccharide polymer having a selected medicament associated therewith. The medicament thus present is provided in a slow release form.
6749867 Delivery system for omeprazole and its salts  
The present invention provides a time-release dosage form for delivering an acid-labile pharmaceutical, such as omeprazole, into the upper portion of the gastrointestinal tract downstream of the...
6743775 Slow release formulations comprising anionic polysaccharide  
A slow release formulation includes a biocompatible anionic polysaccharide material containing glucuronic acid in the polymer chain.
6737082 Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method  
It comprises a compound having antifungal activity as active principle, an inert core and a coating including said active principle, and is characterized in that said inert core has a particle size...
6733790 Microcapsules and processes for making the same using various polymers and chitosans  
A microcapsule having a mean diameter of from about 0.1 to about 5 mm, a membrane and a matrix containing at least one active principle wherein the microcapsule is the product of the process...
6723343 Pharmaceutical tramadol salts  
Disclosed are a compound of tramadol and a sugar substitute, pharmaceutical compositions and sustained-release formulations comprising the compound, and methods of treatment using the compound. The...
6716456 Method for production of microcapsules  
The invention provides a process for microencapsulating a pharmaceutical substrate comprising the steps of: a) adding insoluble or sparingly soluble particles of the substrate to be...